Aberrant structural-functional coupling in adult cannabis users.


Journal

Human brain mapping
ISSN: 1097-0193
Titre abrégé: Hum Brain Mapp
Pays: United States
ID NLM: 9419065

Informations de publication

Date de publication:
01 2019
Historique:
received: 26 03 2018
revised: 09 08 2018
accepted: 11 08 2018
pubmed: 12 9 2018
medline: 9 4 2020
entrez: 12 9 2018
Statut: ppublish

Résumé

Cellular studies indicate that endocannabinoid type-1 retrograde signaling plays a major role in synaptic plasticity. Disruption of these processes by delta-9-tetrahydrocannabinol (THC) could produce alterations either in structural and functional brain connectivity or in their association in cannabis (CB) users. Graph theoretic structural and functional networks were generated with diffusion tensor imaging and resting-state functional imaging in 37 current CB users and 31 healthy non-users. The primary outcome measures were coupling between structural and functional connectivity, global network characteristics, association between the coupling and network properties, and measures of rich-club organization. Structural-functional (SC-FC) coupling was globally preserved showing a positive association in current CB users. However, the users had disrupted associations between SC-FC coupling and network topological characteristics, most perturbed for shorter connections implying region-specific disruption by CB use. Rich-club analysis revealed impaired SC-FC coupling in the hippocampus and caudate of users. This study provides evidence of the abnormal SC-FC association in CB users. The effect was predominant in shorter connections of the brain network, suggesting that the impact of CB use or predispositional factors may be most apparent in local interconnections. Notably, the hippocampus and caudate specifically showed aberrant structural and functional coupling. These structures have high CB1 receptor density and may also be associated with changes in learning and habit formation that occur with chronic cannabis use.

Identifiants

pubmed: 30203892
doi: 10.1002/hbm.24369
pmc: PMC6289814
mid: NIHMS992429
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

252-261

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002529
Pays : United States
Organisme : NIDA NIH HHS
ID : R21 DA035493
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH074983
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA024628
Pays : United States
Organisme : NCCIH NIH HHS
ID : R01 AT009036
Pays : United States
Organisme : National Institutes of Health, Grant/Award Number: UL1TR002529; National Science Foundation, Grant/Award Number: 1342962; National Center for Complementary and Integrative Health, Grant/Award Number: R01AT009036; National Institute of Mental Health, Grant/Award Number: 2R01MH074983; National Institute on Drug Abuse, Grant/Award Numbers: T32DA024628, 5R21DA035493
Pays : International

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Références

Cereb Cortex. 2014 Sep;24(9):2258-67
pubmed: 23551922
Biol Psychiatry. 2010 Jul 1;68(1):61-9
pubmed: 20497901
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
J Neurosci. 2011 Nov 2;31(44):15775-86
pubmed: 22049421
Neuroimage. 2010 Sep;52(3):1059-69
pubmed: 19819337
Brain. 2006 May;129(Pt 5):1081-3
pubmed: 16627464
Learn Mem. 2016 Sep 15;23(10):515-33
pubmed: 27634143
Neuroimage. 2012 Feb 1;59(3):2142-54
pubmed: 22019881
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):2035-40
pubmed: 19188601
Curr Pharm Des. 2014;20(13):2168-85
pubmed: 23829359
Brain. 2011 Oct;134(Pt 10):2912-28
pubmed: 21975588
Dev Cogn Neurosci. 2018 Aug;32:4-7
pubmed: 29051027
J Psychopharmacol. 2014 Nov;28(11):1030-40
pubmed: 25237118
Curr Addict Rep. 2016 Jun;3(2):199-213
pubmed: 27642547
Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):E500-8
pubmed: 26787878
Science. 2002 May 3;296(5569):910-3
pubmed: 11988575
Neuroimage. 2002 May;16(1):241-50
pubmed: 11969331
Cereb Cortex. 2009 Jan;19(1):72-8
pubmed: 18403396
Psychopharmacology (Berl). 2016 Oct;233(19-20):3627-37
pubmed: 27503373
Drug Alcohol Depend. 2014 Jul 1;140:101-11
pubmed: 24838032
Hippocampus. 2009 Aug;19(8):763-72
pubmed: 19156848
CNS Neurosci Ther. 2010 Jun;16(3):e72-91
pubmed: 20406253
Front Psychiatry. 2013 Aug 07;4:79
pubmed: 23966956
J Neurosci. 2001 May 15;21(10):RC146
pubmed: 11319244
Proc Natl Acad Sci U S A. 2014 May 20;111(20):7456-61
pubmed: 24799693
Pharmacol Biochem Behav. 2008 Oct;90(4):501-11
pubmed: 18584858
Schizophr Bull. 2014 Mar;40(2):438-48
pubmed: 24298172
JAMA Psychiatry. 2016 Mar;73(3):292-7
pubmed: 26842658
Brain Connect. 2012;2(1):25-32
pubmed: 22432927
Brain Res. 1991 May 3;547(2):267-74
pubmed: 1909204
Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):19067-72
pubmed: 20956328
Neurobiol Dis. 2015 Jan;73:60-9
pubmed: 25281318
Neuroscience. 1997 Mar;77(2):299-318
pubmed: 9472392
Magn Reson Imaging. 2011 Jul;29(6):777-88
pubmed: 21550747
PLoS Biol. 2008 Jul 1;6(7):e159
pubmed: 18597554
Cereb Cortex. 2005 Sep;15(9):1332-42
pubmed: 15635061
Phys Rev Lett. 2008 Oct 17;101(16):168702
pubmed: 18999722
Brain. 2012 Jul;135(Pt 7):2245-55
pubmed: 22669080
Mol Cell Endocrinol. 2008 Apr 16;286(1-2 Suppl 1):S60-5
pubmed: 18336996
Neuroimage. 2003 Oct;20(2):870-88
pubmed: 14568458
Cereb Cortex. 2013 Jan;23(1):127-38
pubmed: 22275481
PLoS Comput Biol. 2005 Sep;1(4):e42
pubmed: 16201007
Curr Drug Abuse Rev. 2008 Jun;1(2):114-23
pubmed: 19630711
Brain Connect. 2013;3(5):523-35
pubmed: 23980912
JAMA Psychiatry. 2015 Oct;72(10):994-1001
pubmed: 26308883
Neuroimage. 2010 Aug 1;52(1):290-301
pubmed: 20385244
Psychiatry Res Neuroimaging. 2018 Jun 8;278:21-34
pubmed: 29957349
JAMA Psychiatry. 2016 May 1;73(5):472-80
pubmed: 27028160
Hum Brain Mapp. 2019 Jan;40(1):252-261
pubmed: 30203892
PLoS One. 2013;8(2):e55821
pubmed: 23390554
J Psychiatr Res. 2014 Apr;51:68-78
pubmed: 24411594
Trends Cogn Sci. 2013 Dec;17(12):666-82
pubmed: 24238796
Proc Natl Acad Sci U S A. 2015 Jan 20;112(3):887-92
pubmed: 25561541
Cereb Cortex. 2017 Nov 1;27(11):5230-5241
pubmed: 27664961
JAMA Psychiatry. 2013 Aug;70(8):783-92
pubmed: 23739835
Am J Drug Alcohol Abuse. 2002 Nov;28(4):643-52
pubmed: 12492261
Lancet Psychiatry. 2016 Aug;3(8):760-773
pubmed: 27475769
Neuroimage. 2016 Jan 15;125:1063-1078
pubmed: 26481672
Addict Biol. 2017 Jul;22(4):1036-1047
pubmed: 26934839
Nature. 2016 Nov 16;539(7629):369-377
pubmed: 27853201
Psychopharmacology (Berl). 2018 Mar;235(3):849-859
pubmed: 29197984
Curr Pharm Des. 2016;22(42):6366-6379
pubmed: 27549374
Am J Drug Alcohol Abuse. 2013 Nov;39(6):382-91
pubmed: 24200208
Neuroimage. 2013 Oct 15;80:360-78
pubmed: 23707587
JAMA Psychiatry. 2015 Dec;72(12):1235-42
pubmed: 26502112

Auteurs

Dae-Jin Kim (DJ)

Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana.

Ashley M Schnakenberg Martin (AM)

Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana.

Yong-Wook Shin (YW)

Department of Psychiatry, Ulsan University School of Medicine, ASAN Medical Center, Seoul, South Korea.

Hang Joon Jo (HJ)

Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota.

Hu Cheng (H)

Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana.
Imaging Research Facility, Indiana University, Bloomington, Indiana.

Sharlene D Newman (SD)

Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana.
Imaging Research Facility, Indiana University, Bloomington, Indiana.

Olaf Sporns (O)

Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana.
Indiana University Network Science Institute, Indiana University, Bloomington, Indiana.

William P Hetrick (WP)

Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana.

Eli Calkins (E)

Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana.

Brian F O'Donnell (BF)

Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH